Fuqing

What Fuqing does

Fuqing (芙清/FulQun), legally Beijing FulQun Bio-Technology Co. Ltd (北京芙清生物科技有限公司), is a privately held dermatology-grade skincare brand founded in 2014 and headquartered in Beijing, China. The company specializes in the precise management of oily and acne-prone skin through a dual product strategy spanning consumer cosmetics (acne essences, herbal tea daily-disposable ampoules, salicylic acid masks, cleansers, hyaluronic acid serums, collagen lines) and registered medical device functional dressings (medical masks, gels, hyaluronic acid nursing patches, ointment dressings). Its core technology centers on a proprietary antimicrobial peptide branded as Frapertide (十三肽), combined with hyaluronic acid, marketed through a "medical-research co-creation" (医研共创) model that originated in hospital dermatology departments treating acne, dermatitis, eczema, and post-aesthetic procedure recovery. The brand is led by founder Gong Junhua (巩军华) and operates under the legal entity Beijing FulQun Bio-Technology Co. Ltd, with no disclosed parent company, external institutional investment in the structured firmographic data, or public listing.

Fuqing generates revenue through multiple channels: (1) direct-to-consumer e-commerce via a Tmall flagship store and the official website fulqun.com selling cosmetic SKUs; (2) B2B sales of medical dressings and functional gels to hospital dermatology departments, its original channel since founding in 2014; (3) a professional line (童颜乳酸院线版) of lactic acid chemical peels in 12%, 40%, and 80% concentrations sold to medical aesthetic clinics; and (4) co-branded medical device distribution through Ali Health (阿里大药房). A small recurring subscription gates access to 械品 (medical device) product information at 10 yuan per month, and limited-edition Herbal Tea IP collaborations provide episodic brand-extension revenue. Distribution is concentrated in China with no documented international footprint.

Strategic differentiators include the proprietary Frapertide peptide, ten years of category presence (recognized on the 2022 新颜榜 Top 10 Brands list), and dual OTC-clinical positioning. Reported performance indicators include 122% year-over-year growth on Tmall during the 2022 618 shopping festival and approximately 10,000 units sold of the Deep Cleansing Mud Mask during its launch window. No revenue figure, headcount, certifications, or patent portfolio is disclosed in the available data, and a structured funding-rounds array is empty; an unverified entry referencing IDG Capital as lead investor with a $0 disclosed amount and a 2025-12-31 date appears outside the structured data and lacks a source identifier, so it is not treated as a confirmed capital event.

Name

Fuqing

Legal name

Beijing FulQun Bio-Technology Co. Ltd (北京芙清生物科技有限公司)

Website

https://fulqun.com

Company type

Private

Founded year

2014

Operating status

Operating

Short description

Beijing-headquartered dermatology-grade skincare brand founded in 2014, specializing in oily and acne-prone skin management via proprietary antimicrobial peptide (Frapertide) technology. Sells consumer cosmetics and medical device dressings through Tmall DTC, hospital dermatology, and medical aesthetic clinic channels, primarily in China.

Ownership category

akta.pro rank

Product category

Dermatological Skincare

NAICS

Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256), Soap and Cleaning Compound Manufacturing (32561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB), Antibacterial & Medicated Cleansers (e.g., Acne, Antifungal, Antiseptic) (CRABAEAH)

Keywords

• Acne skincare products
• Dermatological skincare brand
• Medical wound dressings
• Antimicrobial peptide skincare
• Skin barrier repair

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Supply Chain, Technology or R&D, Personnel, Operations

Revenue model

1. Cosmetics and Skincare Products: Revenue from selling cosmetic skincare products directly to consumers through Tmall marketplace and official website. Products include acne essences, masks, cleansers, and serums.
2. Medical Device Products (械品): Revenue from medical device/functional dressing products sold to hospitals and clinics. Some medical device information requires paid subscription access (10 yuan/month for members).
3. Professional/Clinical Products (院线系列): Revenue from professional-grade products sold through clinical/medical aesthetic channels, including lactic acid peel products in various concentrations for clinical use.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels10 records

Core offering

Fuqing is a dermatology-grade skincare brand that develops, manufactures, and sells cosmetics and medical device products targeting oily and acne-prone skin. Its portfolio spans consumer acne essences, herbal tea masks, salicylic acid cleansers, and hyaluronic acid serums, as well as Class II medical device functional dressings (masks, gels, patches) used in hospitals and clinics for acne, dermatitis, eczema, and post-aesthetic procedure recovery. The brand follows a medical-cosmetic co-creation model built around its proprietary Frampertide antimicrobial peptide ingredient.

Product overview

Fuqing (芙清) is a dermatology-grade skincare brand founded in 2014, specializing in precision management for oily and acne-prone skin. The company operates a multi-product portfolio consisting of: (1) Core cosmetic products including the Fuqing Acne Essence, Herbal Tea Daily Disposables (Gen 1 and Gen 2), Herbal Tea Mask 2.0, Salicylic Acid Exfoliating Mask, Spot Acne Essence, Cleansing products (Purifying Cleanser, Salicylic Acid Cleanser, Clay Mask), and Hyaluronic Acid Essence and Collagen line (Water, Lotion, Repairing Lotion); (2) Medical device products including Classic Mask, White Mask, Black Mask, Collagen Mask, Medical Gel, Hyaluronic Acid Nursing Patch, Blue Mask, Medical Cleanser, Functional Dressing Gel, and Medical Ointment Dressing XH-Ⅰ Type; (3) Professional-use lactic acid chemical exfoliation products (Childlike Lactic Acid Professional Series); and (4) Limited edition IP collaboration products. The brand follows a medical-research collaborative development model, originally providing dressings for dermatologists to treat acne, dermatitis, eczema, and post-procedure recovery.

Differentiator

Problem solved

Functional benefit

Brands

• 凉茶系列 (Herbal Tea Series): Signature product line featuring the凉茶 (herbal tea) mask and related skincare items, marketed with herbal/traditional Chinese medicine positioning.

Products and services

• Fuqing Acne Essence (芙清祛痘精华液) Five-dimensional acne treatment essence featuring the proprietary Frampertide antimicrobial peptide, designed to address root causes of acne and comprehensively improve acne-prone skin for individual consumers.
• Fuqing Herbal Tea Daily Disposables (芙清凉茶次抛) Herbal tea-formulated daily disposable ampoules for acne treatment and redness reduction; a signature product line sold to individual consumers through e-commerce channels.
• Fuqing Herbal Tea Mask 2.0 (芙清凉茶面膜2.0) Upgraded herbal tea mask with enhanced formulation for acne-prone skin care, sold as a consumer skincare item.
• Salicylic Acid Exfoliating Mask (水杨酸焕肤面膜) Salicylic acid-based exfoliating mask for deep cleansing and skin polishing for oily acne-prone skin, marketed to individual consumers.
• Fuqing Spot Acne Essence (芙清点痘精华) Targeted spot treatment essence for individual acne blemishes sold to individual consumers.
• Fuqing Purifying Cleanser (芙清净润洁面) Gentle purifying facial cleanser for acne-prone and sensitive skin, sold to individual consumers.
• Fuqing Salicylic Acid Cleanser (芙清水杨酸洁面) Salicylic acid-infused cleanser for deep pore cleansing and acne prevention, sold to individual consumers.
• Fuqing Cleansing Clay Mask (芙清清洁泥膜) Deep cleansing clay mask for oil control and pore refinement, sold to individual consumers through e-commerce channels.
• Fuqing Hyaluronic Acid Essence (芙清玻尿酸精华) Hyaluronic acid serum for deep hydration and skin barrier support, sold to individual consumers.
• Fuqing Collagen Skincare Line (胶原水/胶原乳/修复乳) Collagen water, collagen lotion, and barrier-repairing lotion line for hydration, elasticity, and skin barrier support, sold to individual consumers.
• Medical Healing Functional Dressing (医用促愈功能性敷料) Class II medical device functional dressings in mask and gel formats for skin barrier repair, wound healing, and auxiliary treatment of moderate-to-severe acne; sold to hospitals, clinics, and consumers through e-commerce.
• Medical Ointment Dressing XH-Ⅰ Type (医用膏体敷料XH-Ⅰ型) Medical-grade ointment dressing for non-chronic wound and surrounding skin cleansing and care; a Class II medical device product.
• Fuqing Medical Mask Series (经典膜/白膜/黑膜/胶原膜/蓝膜) Medical-grade facial masks (Classic, White, Black, Collagen, Blue variants) for wound healing, skin barrier repair, and post-procedure recovery, primarily supplied to hospitals and clinics.
• Fuqing Medical Gel and Nursing Patch (医用凝胶/透明质酸纳护理贴) Medical-grade topical gel and hyaluronic acid nursing patch for skin barrier repair, wound healing, and post-aesthetic procedure recovery, supplied to hospitals and clinics.
• Childlike Lactic Acid Professional Series (童颜乳酸院线版系列) Professional-grade lactic acid chemical peel/exfoliation products in various concentrations (12%, 40%, 80%) packaged in clinical formats (15g, 5g), sold through medical aesthetic clinics and professional skincare channels.

Quantifiable outcome

• 122% growth during 618 shopping festival period (2022)
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Two partnerships are on record, tiered minor and core.

• Ali Health (阿里大药房)minorChannel Partner/ Reseller/ DistributorCo-branded product collaboration - 芙清医用促愈功能性敷料阿里大药房联名款 (Medical Healing Functional Dressing Ali Pharmacy co-branded edition). Distributed through Alibaba's pharmacy channel.
• Chinese Medicine External Treatment Academic CommunitycoreStrategic or Co-development PartnerStrategic collaboration with traditional Chinese medicine external treatment experts for developing acne treatment solutions combining modern skincare technology with traditional Chinese medicine wisdom. Multiple academic presentations and research initiatives.

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Winona (薇诺娜): Bloomage Biotech's flagship dermocosmetics brand and the dominant Chinese player in medical-grade skincare for sensitive skin. Most direct comparable: similar hospital-channel origins, similar position in dermatologist-recommended acne/sensitive-skin products, and similar Tmall D2C presence.
• Dr. Yu / Yuze (玉泽): Shanghai Jahwa's dermocosmetics brand positioned on skin barrier repair. Directly comparable medical-cosmetic co-creation model, hospital dermatology credibility, and acne/sensitive-skin treatment positioning.
• Comfy / Kefumei (可复美): Another leading Chinese medical dressing and post-procedure skincare brand owned by Giant Biogene. Comparable collagen-based product positioning, hospital and e-commerce dual channel, and similar acne-prone / post-aesthetic consumer focus.
• Fuerda / Pei Kang (敷尔佳): Leading Chinese medical dressing and functional skincare brand with strong acne-treatment positioning. Closely comparable on medical-device heritage, hospital channel, Tmall flagship presence, and acne-prone skin target consumer.

Broad incumbents

• Vichy: L'Oréal-owned dermocosmetics brand with strong hospital/dermatologist endorsement model and sensitive-skin positioning. Comparable on the medical-cosmetic co-creation approach that Fuqing explicitly pursues.
• La Roche-Posay: L'Oréal-owned international dermocosmetics leader. Globally establishes the dermocosmetics category positioning that Fuqing is emulating in China; comparable on medical-grade credibility, sensitive/acne-prone skin positioning, and clinical-channel heritage.
• Proya (珀莱雅): One of China's largest mass-market skincare CPG companies listed on the Shanghai Stock Exchange. Competes with Fuqing on Tmall flagship and broader Chinese consumer skincare, though focused on a wider portfolio rather than acne specialty.
• Marubi (丸美): Major Chinese skincare CPG company with broad product portfolio and significant Tmall presence. Comparable as a Chinese CPG skincare competitor operating on similar e-commerce platforms, though at a larger scale and broader positioning.
• Avène: Pierre Fabre-owned dermocosmetics brand with thermal spring water heritage and sensitive-skin positioning. Comparable on the pharmacy-channel-to-consumer-brand evolution that Fuqing has executed in China.

Emerging players

• Chuangfukang (创福康): Chinese collagen-based medical dressing brand with strong hospital channel positioning. Comparable in the medical-device-for-skincare category, particularly for post-procedure and acne-adjacent indications, though smaller and more hospital-focused than Fuqing's consumer-facing D2C model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fuqing